Author Correction: Introducing PIONEER: a project to harness big data in prostate cancer research

Collaborators, Affiliations

PIONEER Consortium:
Emelie Andersson, Heidi Arala, Anssi Auvinen, Chris Bangma, Danny Burke, Antonella Cardone, Joaquin Casariego, Guido Cuperus, Saeed Dabestani, Francesco Esperto, Nicola Fossati, Adam Fridhammar, Giorgio Gandaglia, Delila Gasi Tandefelt, Friedemann Horn, Johannes Huber, Jonas Hugosson, Henkjan Huisman, Andreas Josefsson, Olavi Kilkku, Markus Kreuz, Michael Lardas, Joe Lawson, Florence Lefresne, Stephane Lejeune, Elaine Longden-Chapman, Gordon McVie, Lisa Moris, Nicolas Mottet, Teemu Murtola, Charlie Nicholls, Karl H Pang, Katie Pascoe, Marta Picozzi, Karin Plass, Pasi Pohjanjousi, Matthew Reaney, Sebastiaan Remmers, Paul Robinson, Jack Schalken, Max Schravendeel, Thomas Seisen, Angela Servan, Kirill Shiranov, Robert Snijder, Carl Steinbeisser, Nesrine Taibi, Kirsi Talala, Derya Tilki, Thomas Van den Broeck, Zdravko Vassilev, Olli Voima, Eleni Vradi, Reg Waldeck, Ward Weistra, Peter-Paul Willemse, Manfred Wirth, Russ Wolfinger, Nazanin Zounemat Kermani

¹ Academic Urology Unit, University of Aberdeen, Aberdeen, UK. m.i.omar@abdn.ac.uk.
² Erasmus MC, Rotterdam, Netherlands.
³ Guidelines Office, European Association of Urology, Arnhem, Netherlands.
⁴ Astellas, Leiden, The Netherlands.
⁵ Imperial College London, London, UK.
⁶ IQVIA, London, UK.
⁷ Bayer AG, Berlin, Germany.
⁸ Association EISBM, Vourles, France.
⁹ Translational Oncology and Urology Research, King's College London, London, UK.
¹⁰ European Alliance for Personalised Medicine (EAPM), Brussels, Belgium.
¹¹ Department of Translational Medicine, Lund University, Lund, Sweden.
¹² Department of Urology and Division of Experimental Oncology, Urological Research Institute, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.
¹³ The Hyve, Utrecht, Netherlands.
¹⁴ Sanofi, Chilly-Mazarin, France.
¹⁵ Pinsent Masons, Leeds, UK.
¹⁶ Tampere University (TAU), Tampere, Finland.
¹⁷ SAS, Tervuren, Belgium.
¹⁸ Weizmann Institute, Rehovot, Israel.
¹⁹ The Swedish Institute for Health Economics (IHE), Stockholm, Sweden.
²⁰ Academic Urology Unit, University of Aberdeen, Aberdeen, UK.
²¹ Fraunhofer IZI, Leipzig, Germany.
²² ttopstart, Utrecht, Netherlands.

Published Erratum

Muhammad Imran Omar et al. Nat Rev Urol. 2020 Aug.

. 2020 Aug;17(8):482.

doi: 10.1038/s41585-020-0355-3.

PIONEER Consortium:
Emelie Andersson, Heidi Arala, Anssi Auvinen, Chris Bangma, Danny Burke, Antonella Cardone, Joaquin Casariego, Guido Cuperus, Saeed Dabestani, Francesco Esperto, Nicola Fossati, Adam Fridhammar, Giorgio Gandaglia, Delila Gasi Tandefelt, Friedemann Horn, Johannes Huber, Jonas Hugosson, Henkjan Huisman, Andreas Josefsson, Olavi Kilkku, Markus Kreuz, Michael Lardas, Joe Lawson, Florence Lefresne, Stephane Lejeune, Elaine Longden-Chapman, Gordon McVie, Lisa Moris, Nicolas Mottet, Teemu Murtola, Charlie Nicholls, Karl H Pang, Katie Pascoe, Marta Picozzi, Karin Plass, Pasi Pohjanjousi, Matthew Reaney, Sebastiaan Remmers, Paul Robinson, Jack Schalken, Max Schravendeel, Thomas Seisen, Angela Servan, Kirill Shiranov, Robert Snijder, Carl Steinbeisser, Nesrine Taibi, Kirsi Talala, Derya Tilki, Thomas Van den Broeck, Zdravko Vassilev, Olli Voima, Eleni Vradi, Reg Waldeck, Ward Weistra, Peter-Paul Willemse, Manfred Wirth, Russ Wolfinger, Nazanin Zounemat Kermani

¹ Academic Urology Unit, University of Aberdeen, Aberdeen, UK. m.i.omar@abdn.ac.uk.
² Erasmus MC, Rotterdam, Netherlands.
³ Guidelines Office, European Association of Urology, Arnhem, Netherlands.
⁴ Astellas, Leiden, The Netherlands.
⁵ Imperial College London, London, UK.
⁶ IQVIA, London, UK.
⁷ Bayer AG, Berlin, Germany.
⁸ Association EISBM, Vourles, France.
⁹ Translational Oncology and Urology Research, King's College London, London, UK.
¹⁰ European Alliance for Personalised Medicine (EAPM), Brussels, Belgium.
¹¹ Department of Translational Medicine, Lund University, Lund, Sweden.
¹² Department of Urology and Division of Experimental Oncology, Urological Research Institute, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.
¹³ The Hyve, Utrecht, Netherlands.
¹⁴ Sanofi, Chilly-Mazarin, France.
¹⁵ Pinsent Masons, Leeds, UK.
¹⁶ Tampere University (TAU), Tampere, Finland.
¹⁷ SAS, Tervuren, Belgium.
¹⁸ Weizmann Institute, Rehovot, Israel.
¹⁹ The Swedish Institute for Health Economics (IHE), Stockholm, Sweden.
²⁰ Academic Urology Unit, University of Aberdeen, Aberdeen, UK.
²¹ Fraunhofer IZI, Leipzig, Germany.
²² ttopstart, Utrecht, Netherlands.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Introducing PIONEER: a project to harness big data in prostate cancer research.
Omar MI, Roobol MJ, Ribal MJ, Abbott T, Agapow PM, Araujo S, Asiimwe A, Auffray C, Balaur I, Beyer K, Bernini C, Bjartell A, Briganti A, Butler-Ransohoff JE, Campi R, Cavelaars M, De Meulder B, Devecseri Z, Voss MD, Dimitropoulos K, Evans-Axelsson S, Franks B, Fullwood L, Horgan D, Smith EJ, Kiran A, Kivinummi K, Lambrecht M, Lancet D, Lindgren P, MacLennan S, MacLennan S, Nogueira MM, Moen F, Moinat M, Papineni K, Reich C, Reiche K, Rogiers S, Sartini C, van Bochove K, van Diggelen F, Van Hemelrijck M, Van Poppel H, Zong J, N'Dow J; PIONEER Consortium. Omar MI, et al. Nat Rev Urol. 2020 Jun;17(6):351-362. doi: 10.1038/s41585-020-0324-x. Epub 2020 May 27. Nat Rev Urol. 2020. PMID: 32461687 Review.